Winthrop Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Winthrop Capital Management's IBB Position: Q3 2026 in Review
Winthrop Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 81 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #218.
Winthrop Capital Management first reported a position in IBB in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.6M in Q4 2023. 1,031 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Winthrop Capital Management held 81 shares of iShares Biotechnology ETF worth $17.1K as of Q3 2026.
- Winthrop Capital Management left its iShares Biotechnology ETF share count unchanged in Q3 2026.
- iShares Biotechnology ETF made up ﹤0.01% of Winthrop Capital Management's portfolio in Q3 2026, its #218 holding.
- Winthrop Capital Management first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 9 quarters since.
- Winthrop Capital Management's iShares Biotechnology ETF position peaked at $2.6M in Q4 2023.
- 1,031 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Winthrop Capital Management's 13F filing for Q3 2026, filed 5 Nov 2026.